C&I Capital

C&I Capital is a venture capital firm founded in 2016 and located in Beijing, China. The firm specializes in investing in various sectors, including information technology, advanced manufacturing, and enterprise services. By concentrating on these industries, C&I Capital aims to support innovative companies and foster growth within the Chinese market.

Xia, Chaoyang

Founding Partner

7 past transactions

Care

Seed Round in 2021
Care is an innovative medical technology company developing medical and technological solutions for neurological diseases. Care researches and develops intelligent solutions, such as new software, hardware, and AI technologies, for screening, diagnosis, treatment, and research on neurological diseases.

Think Energy

Seed Round in 2021
Shengke Energy is a high-tech enterprise focusing on safety solutions for new energy vehicle power batteries and energy storage systems. It has developed and innovated several cutting-edge technologies and equipment products, including battery thermal safety analysis, safe fast charging technology, battery system big data diagnosis, and fault warning technology, which can be applied to the fields of new energy vehicles and energy storage, greatly improving system safety and stability, and empowering batteries with wisdom.

Youibot

Seed Round in 2020
Youibot has researched and developed autonomous mobile robot platform independently, based on the latest generation of laser radar and visual real-time SLAM map creation and navigation technology. Equipped with indoor and outdoor robot navigation systems with core technology advantages, Youibot provides domestic first-class intelligent mobile robot systems and highly competitive industry solutions.

CytoNiche

Series A in 2019
CytoNiche focuses on the development of 3D micro-organization engineering technology. The core technology is derived from the transformation of Tsinghua University's achievements. Based on its original research technology, Huasheng Bio has launched a series of related products and services, including customized, large-scale, automated and intelligent stem cell culture. Amplification process; 3D stem cell micro-tissue regeneration treatment of new drugs and 3D cell high-throughput drug screening products.

Kuangren Xueyuan

Series A in 2019
Kuangren Xueyuan provides technical services, technical development, technical consultation, technical exchange, technology transfer, technology promotion, computer system services, software development, advertising design, and education consulting services.

Bvaluate

Angel Round in 2018
Bvaluate is a big data modeling analysis, natural language processing, and image recognition technology. Its technical research and development and consulting teams are drawn from TRS, microsoft headquarters, wall street, adobe, and other institutions, and it serves as the foundation for consensus reached by users in the secondary market, various platforms, and project parties, as the catalyst for the current blockchain industry to return to the concept of value.

TsingTech

Angel Round in 2017
TsingTech is a producer of power assembly systems. They offer electronics and power transmission solutions. They offer services for industries. Their customers' inquiries are addressed through phone, email, and online applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.